SenzaGen AB (publ)

kr 4.95As of Sun 8 Nov 2026, 12:00 UTC
STO:SENZAHealthcare
Country Sweden
PE (Fwd) •••
TSR 9Y CAGR (21.16%)
Div yield —
ROE (7.04%)
Diagnostics & Research
Beta (5Y) 0.47
PE TTM —
TSR TTM (19.90%)
Mkt cap kr 160.9M
ROIC (9.42%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 4.76
(3.86%)
(90.87%)
Hold 5|0|4|12|2
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.07
0.08
0.09
0.09
8.52%
21.77%
28.74%
21.45%
Revenuekr M
10.21
10.63
10.75
11.30
2.48%
3.61%
5.51%
13.17%
Peers (US$16.27M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.392
0.043
0.036
EBIT/Intx
4.581
1.828
2.195
Own earn%
(20.83)
58.30
58.42
Sh yield%
25.88
39.32
39.64
Owners
Insiders/Inst%
10.01
38.65
Short interest%
2.90
SBC / revenue%
1.00
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
0–7
$1 testx
—
Incr. ROIC%
28